Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Clinical trial NCT00570700 · COMPLETED

Trial details

NCT number: NCT00570700
Sponsor: University of California, Irvine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-refractory Prostate Cancer Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Prostate Cancer Recurrent Prostate Cancer

Start date: 2007-07-01
Primary completion: 2012-02-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.